Cargando…
Identifying Novel Genes and Variants in Immune and Coagulation Pathways Associated with Macular Degeneration
PURPOSE: To select individuals and families with a low genetic burden for age-related macular degeneration (AMD), to inform the clinical diagnosis of macular disorders, and to find novel genetic variants associated with maculopathies. DESIGN: Genetic association study based on targeted and whole-exo...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574715/ https://www.ncbi.nlm.nih.gov/pubmed/36275200 http://dx.doi.org/10.1016/j.xops.2022.100206 |
_version_ | 1784811162200702976 |
---|---|
author | Huan, Tianxiao Cheng, Shun-Yun Tian, Bo Punzo, Claudio Lin, Haijiang Daly, Mark Seddon, Johanna M. |
author_facet | Huan, Tianxiao Cheng, Shun-Yun Tian, Bo Punzo, Claudio Lin, Haijiang Daly, Mark Seddon, Johanna M. |
author_sort | Huan, Tianxiao |
collection | PubMed |
description | PURPOSE: To select individuals and families with a low genetic burden for age-related macular degeneration (AMD), to inform the clinical diagnosis of macular disorders, and to find novel genetic variants associated with maculopathies. DESIGN: Genetic association study based on targeted and whole-exome sequencing. PARTICIPANTS: A total of 758 subjects (481 individuals with maculopathy and 277 controls), including 316 individuals in 72 families. METHODS: We focused on 150 genes involved in the complement, coagulation, and inflammatory pathways. Single-variant tests were performed on 7755 variants shared among ≥ 5 subjects using logistic regression. Gene-based tests were used to evaluate aggregate effects from rare and low-frequency variants (at minor allele frequency [MAF] ≤ 5% or ≤ 1%) in a gene using burden tests. For families whose affected members had a low burden of genetic risk based on known common and rare variants related to AMD, we searched for rare variants (MAF < 0.001) whose risk alleles occurred in ≥ 80% of affected individuals but not in controls. Immunohistochemistry was performed to determine the protein expression of a novel gene (coagulation factor II thrombin receptor-like 2 [F2RL2]) in retinal tissues. MAIN OUTCOME MEASURES: Genotypes and phenotypes of macular degeneration. RESULTS: We confirmed the association of a synonymous variant in complement factor H (Ala473, rs2274700, proxy to intronic rs1410996, r(2) = 1) with maculopathy (odds ratio, 0.64; P = 4.5 × 10(–4)). Higher AMD polygenic risk scores (PRSs) were associated with intermediate and advanced AMD. Among families with low PRSs and no known rare variants for maculopathy, we identified 2 novel, highly penetrant missense rare variants in ADAM15, A disintegrin and metalloprotease, metallopeptidase domain 15 (p.Arg288Cys) and F2RL2 (p.Leu289Arg). Immunohistochemistry analyses revealed F2RL2 protein expression in cone photoreceptor outer segments and Müller glia cells of human and pig retinas. Coagulation factor II thrombin receptor-like 2 expression appeared increased in fibrotic areas in advanced AMD samples with neovascularization, suggesting that F2RL2 may play a role in the progression to advanced macular disease. CONCLUSIONS: New missense rare variants in the genes ADAM15 and F2RL2 were associated with maculopathies. Results suggest that novel genes related to the coagulation and immune pathways may be involved in the pathogenesis of macular diseases. |
format | Online Article Text |
id | pubmed-9574715 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | Elsevier |
record_format | MEDLINE/PubMed |
spelling | pubmed-95747152022-10-21 Identifying Novel Genes and Variants in Immune and Coagulation Pathways Associated with Macular Degeneration Huan, Tianxiao Cheng, Shun-Yun Tian, Bo Punzo, Claudio Lin, Haijiang Daly, Mark Seddon, Johanna M. Ophthalmol Sci Original Articles PURPOSE: To select individuals and families with a low genetic burden for age-related macular degeneration (AMD), to inform the clinical diagnosis of macular disorders, and to find novel genetic variants associated with maculopathies. DESIGN: Genetic association study based on targeted and whole-exome sequencing. PARTICIPANTS: A total of 758 subjects (481 individuals with maculopathy and 277 controls), including 316 individuals in 72 families. METHODS: We focused on 150 genes involved in the complement, coagulation, and inflammatory pathways. Single-variant tests were performed on 7755 variants shared among ≥ 5 subjects using logistic regression. Gene-based tests were used to evaluate aggregate effects from rare and low-frequency variants (at minor allele frequency [MAF] ≤ 5% or ≤ 1%) in a gene using burden tests. For families whose affected members had a low burden of genetic risk based on known common and rare variants related to AMD, we searched for rare variants (MAF < 0.001) whose risk alleles occurred in ≥ 80% of affected individuals but not in controls. Immunohistochemistry was performed to determine the protein expression of a novel gene (coagulation factor II thrombin receptor-like 2 [F2RL2]) in retinal tissues. MAIN OUTCOME MEASURES: Genotypes and phenotypes of macular degeneration. RESULTS: We confirmed the association of a synonymous variant in complement factor H (Ala473, rs2274700, proxy to intronic rs1410996, r(2) = 1) with maculopathy (odds ratio, 0.64; P = 4.5 × 10(–4)). Higher AMD polygenic risk scores (PRSs) were associated with intermediate and advanced AMD. Among families with low PRSs and no known rare variants for maculopathy, we identified 2 novel, highly penetrant missense rare variants in ADAM15, A disintegrin and metalloprotease, metallopeptidase domain 15 (p.Arg288Cys) and F2RL2 (p.Leu289Arg). Immunohistochemistry analyses revealed F2RL2 protein expression in cone photoreceptor outer segments and Müller glia cells of human and pig retinas. Coagulation factor II thrombin receptor-like 2 expression appeared increased in fibrotic areas in advanced AMD samples with neovascularization, suggesting that F2RL2 may play a role in the progression to advanced macular disease. CONCLUSIONS: New missense rare variants in the genes ADAM15 and F2RL2 were associated with maculopathies. Results suggest that novel genes related to the coagulation and immune pathways may be involved in the pathogenesis of macular diseases. Elsevier 2022-08-08 /pmc/articles/PMC9574715/ /pubmed/36275200 http://dx.doi.org/10.1016/j.xops.2022.100206 Text en © 2022 Published by Elsevier Inc. on behalf of the American Academy of Ophthalmology. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/). |
spellingShingle | Original Articles Huan, Tianxiao Cheng, Shun-Yun Tian, Bo Punzo, Claudio Lin, Haijiang Daly, Mark Seddon, Johanna M. Identifying Novel Genes and Variants in Immune and Coagulation Pathways Associated with Macular Degeneration |
title | Identifying Novel Genes and Variants in Immune and Coagulation Pathways Associated with Macular Degeneration |
title_full | Identifying Novel Genes and Variants in Immune and Coagulation Pathways Associated with Macular Degeneration |
title_fullStr | Identifying Novel Genes and Variants in Immune and Coagulation Pathways Associated with Macular Degeneration |
title_full_unstemmed | Identifying Novel Genes and Variants in Immune and Coagulation Pathways Associated with Macular Degeneration |
title_short | Identifying Novel Genes and Variants in Immune and Coagulation Pathways Associated with Macular Degeneration |
title_sort | identifying novel genes and variants in immune and coagulation pathways associated with macular degeneration |
topic | Original Articles |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9574715/ https://www.ncbi.nlm.nih.gov/pubmed/36275200 http://dx.doi.org/10.1016/j.xops.2022.100206 |
work_keys_str_mv | AT huantianxiao identifyingnovelgenesandvariantsinimmuneandcoagulationpathwaysassociatedwithmaculardegeneration AT chengshunyun identifyingnovelgenesandvariantsinimmuneandcoagulationpathwaysassociatedwithmaculardegeneration AT tianbo identifyingnovelgenesandvariantsinimmuneandcoagulationpathwaysassociatedwithmaculardegeneration AT punzoclaudio identifyingnovelgenesandvariantsinimmuneandcoagulationpathwaysassociatedwithmaculardegeneration AT linhaijiang identifyingnovelgenesandvariantsinimmuneandcoagulationpathwaysassociatedwithmaculardegeneration AT dalymark identifyingnovelgenesandvariantsinimmuneandcoagulationpathwaysassociatedwithmaculardegeneration AT seddonjohannam identifyingnovelgenesandvariantsinimmuneandcoagulationpathwaysassociatedwithmaculardegeneration |